Full Archive

Asbestos Disease Awareness Organization celebrates tenth annual week

Ten years ago, the Asbestos Disease Awareness Organization (ADAO) expanded their reach by making the first week of April National Asbestos Awareness Week. Soon after, other countries suffering from the carcinogen’s deadly effects joined and transformed the week into a global occasion. The ADAO started in 2004 to provide a[…]

Read More »

New study suggests breast cancer drug may shrink mesothelioma tumors

After new evidence surfaced suggesting the enzyme aromatase is associated with malignant mesothelioma, Italian scientists began testing breast cancer drug Aromasin (exemestane) on mice and mesothelioma cells. Designed to inhibit aromatase, Aromasin curbs cell growth in breast cancer patients by helping reduce the amount of estrogen in the body. In[…]

Read More »

Alimta remains best treatment for victims of malignant pleural mesothelioma

For those with inoperable malignant pleural mesothelioma, Alimta (permetrexed) combined with cisplatin remains the top treatment. Japanese researchers recently analyzed the results of 30 patients taking either Gemzar or the Alimta combination and compared complications, disease control and survival rates. Thirty mesothelioma cases were examined featuring 13 patients taking Gemzar[…]

Read More »

Research shows both mesothelioma surgeries produce results

A recent study by United Kingdom researchers discovered when considering the mesothelioma surgery options, there is no clear choice. Cancer centers and mesothelioma doctors often disagree about which procedure to offer between extrapleural pneumonectomy  (EPP) and pleurectomy/decotication (P/D). The surgeries attempt to either remove and cure the patient or relieve[…]

Read More »

Skip to content